Researchers found that long-term antibiotic use during adolescence disrupts the healthy gut microbiome, leading to changes in liver metabolism that promotes central fat accumulation. The study suggests that antibiotic treatment may have lasting detrimental effects on liver metabolism and promote adiposity.
Researchers developed a deep learning-based AI model to automate cirrhosis identification using large amounts of data from EHRs. The model successfully identified patients with cirrhosis with a precision of 97%, offering potential for early diagnosis and improved management of the disease.
A study from George Mason University found elevated insulin and hemoglobin A1C levels in early elementary-aged Latino youth with obesity, a risk factor for cardiometabolic diseases. The research aims to identify at-risk children and implement interventions earlier to mitigate the effects of childhood obesity.
Researchers have developed a new imaging approach to diagnose advanced non-alcoholic fatty liver disease (NASH). The enzyme-sensitive nanoprobe emits signals that can be detected by MRI techniques, providing more accurate and sensitive data for diagnosis. This breakthrough aims to improve the treatment outcomes of NASH patients.
A hormone called FGF21 protects mice from ethanol-induced loss of balance and righting reflex by activating a specific part of the brain that controls alertness. The study reveals that higher FGF21 concentrations can dramatically accelerate recovery from intoxication.
A new study by Weill Cornell Medicine found that the FDA's mandate to limit opioid-acetaminophen combinations resulted in significant reductions in liver injuries. The mandate, implemented in 2014, limited the dosage of acetaminophen in these drugs, leading to a decline in hospitalizations and acute liver failure cases.
Researchers found that COVID-19 infections are linked to an increased risk of developing liver problems, acute pancreatitis, and other GI disorders. The study analyzed over 14 million medical records and estimated that SARS-CoV-2 infections have contributed to over 6 million new cases of GI disorders in the US.
A US FDA mandate to limit acetaminophen dosage in pills combining it with opioids significantly reduced hospitalizations and acute liver failure cases. Researchers found a persistent decline in yearly rates of these cases after the mandate was implemented in 2014.
A new study shows that patients with liver cirrhosis have a lower immune response to COVID-19 vaccines, but this does not affect the vaccines' effectiveness. Age, type of vaccine, and viral hepatitis etiology also play a role in immune responses.
A study by researchers at TUM found that gut bacteria play a crucial role in liver regeneration. The microbiome produces short-chain fatty acids, which are essential for liver cell growth and division. In mice treated with antibiotics, liver regeneration was delayed or not possible, but a
Researchers created human organoid models of fatty liver disease to shed light on drug responses and disease biology. The models identified a common mechanism for effective drugs that block lipid generation from sugars, suggesting personalized medicine applications.
A recent study published in JHEP Reports found that individuals with low thigh muscle volume and high muscle fat infiltration had an increased mortality risk. The researchers also discovered that poor muscle health was not associated with a worsened prognosis in people with fatty liver disease.
Researchers discovered that combining ferroptosis induction with immune checkpoint inhibition reduces liver tumour growth and metastases, offering a promising new approach for treating liver cancer
Researchers at Washington State University found that CBD inhibits a key enzyme for nicotine metabolism, slowing down its effects and allowing smokers to wait before feeling the urge to smoke. The study suggests that CBD could be a useful tool in reducing harm from smoking and quitting nicotine addiction.
A mutant SRSF1 gene may cause severe nonalcoholic fatty liver disease (NASH), researchers have found. Mice lacking the gene develop all three hallmarks of NASH: excess fat, inflammation, and scarring in the liver. The study suggests that DNA damage in liver cells triggers this pathology, highlighting the need to protect the genome.
Researchers have identified a blood protein snapshot that documents changes in patients with severe liver disease caused by heavy drinking, potentially leading to a simple blood test for diagnosis and treatment monitoring.
A recent study published in the British Journal of Surgery found that patients undergoing liver surgery fare better in higher-volume hospitals. In-hospital mortality rates were lower in these facilities, with a rate of 2.8%, compared to 3% in lower-volume hospitals.
A study identified an antibody candidate that blocks the protein VEGF-B, presenting a possible therapeutic option for fatty liver disease. The treatment method involves keeping fatty acids in adipose tissue to prevent liver accumulation.
A team of researchers from MedUni Vienna has identified the polymeric immunoglobulin receptor (pIgR) as a key player in protecting against alcohol-induced liver damage. The study found that pIgR-mediated secretion of antibodies in the intestines helps to prevent bacterial translocation and inflammation in the liver.
A new study finds that dietary choline deficiency can cause profound negative effects on the body, including organ damage and changes in brain pathology associated with Alzheimer's disease. The research highlights the importance of adequate choline intake to protect against neurodegeneration and improve overall health.
A large cohort study found that long-term low-dose hydroxychloroquine use is associated with a low risk of developing retinopathy, while higher doses increase the risk. Regular screening can identify the issue at an early stage.
Researchers found that inhibiting HSF1 signaling reduces hepatoblastoma growth and induces apoptosis, suggesting it as a viable pharmacologic target. The study also identified HSF1's role in tumor aggressiveness and its potential association with mortality.
A new study by the University of Coimbra found that higher coffee intake is associated with reduced NAFLD severity in overweight people with T2D. Caffeine and polyphenols in coffee may help alleviate liver fibrosis and improve glucose homeostasis.
A study published in Journal of Hepatology found that efficient priming of HBV-specific CD4 T cells is crucial for the success of therapeutic hepatitis B vaccination. The researchers developed a novel heterologous prime-boost vaccine, TherVacB, which induced antiviral efficacy in preclinical mouse models.
Researchers from prominent institutions discuss hepatocellular carcinoma's pathogenesis, genomic heterogeneity, and targeted therapy options. The review aims to characterize HCC's complexities and develop clinically relevant biomarkers for better management.
Researchers at USC Keck School of Medicine found that liver cancer cells hijack circadian clock proteins to replicate and spread. Inhibiting these proteins can prevent cancer cell multiplication and potentially improve outcomes for patients with liver cancer.
African patients with chronic hepatitis B face limited access to treatment due to inadequate guidelines. Researchers propose lower treatment thresholds and better adapted guidelines for the African population.
A study published in Journal of Hepatology found that non-alcoholic fatty liver disease (NAFLD) can cause a decrease in oxygen supply to the brain and inflammation to brain tissue. The research identified Monocarboxylate Transporter 1 (MCT1) as a potential therapeutic target for protecting against NAFLD-induced brain dysfunction.
Researchers at Duke University discovered that glassfrogs store nearly 90% of their circulating red blood cells in their liver when they want to be transparent. This helps them blend in with their surroundings and avoid predation during the day.
Researchers found that a senolytic drug can preserve the biliary tract's regenerative capacity in liver cells damaged by cold storage. This discovery could lead to improved liver transplant success rates, saving lives and reducing costs associated with transplant failure.
A recent study published in Clinical Gastroenterology and Hepatology found that complete alcohol abstinence significantly reduces complications of liver cirrhosis and increases lifespan in patients with pronounced portal hypertension. Regular medical check-ups are crucial for those affected.
A Cedars-Sinai study found that even subtle forms of liver disease directly impact heart health, with elevated FIB-4 scores associated with abnormalities in heart function and vascular dimension. Cardiac MRI scans revealed that nearly 86% of patients had at least one heart abnormality.
Researchers found that dietary saturated/trans fats, but not cholesterol, can trigger hepatic angiogenesis and lymphangiogenesis in mice, leading to the promotion of hepatic tumors. This process is driven by the JNK-HIF1α-VEGF-C axis.
Researchers from the Leibniz Institute for Food Systems Biology have identified three metabolites as potential biomarkers for individual coffee consumption. These biomarkers could help determine the health value of coffee by objectively verifying coffee consumption levels.
A new study found that obeticholic acid can reverse cognitive impairment in patients with cholestatic liver disease, improving short-term memory and restoring brain function. The study used a rodent model of bile duct ligation-induced cholestasis and found that the drug significantly improved cognitive deficits.
Researchers discovered that a single copy of the Z mutation can significantly alter AAT protein processing, leading to impaired metabolic and mitochondrial function. This finding has implications for understanding and treating alpha-1 antitrypsin deficiency associated liver disease.
Researchers identify an off-patent liver disease drug that can prevent SARS-CoV-2 entry into cells, potentially offering protection against future variants. The study used a unique combination of 'mini-organs', animal studies, and human subjects to demonstrate the drug's effectiveness.
A new study pinpoints the first-ever domestication of cats to nearly 10,000 years ago in the Fertile Crescent region. Genetic analysis reveals that humans' transition from hunter-gatherers to farmers sparked the bond between humans and rodents-eating cats, leading to their migration with humans worldwide.
A new study finds that COVID-19 patients exhibit higher liver stiffness months after infection, indicating possible long-term liver damage. The study also suggests that even pre-pandemic patients showed increased liver stiffness, likely due to changing referral patterns during the pandemic.
Researchers discovered three essential amino acids - leucine, valine, and tryptophan - as potential metabolic biomarkers for HCC. The study used metabolomics to analyze the differences in tumor and non-tumor tissue metabolomes, revealing striking differences that could aid in diagnosis.
A Rutgers study found that COVID-19 patients, especially those treated with antibiotics, experience significant disruptions in their gut microbiome balance. This imbalance may lead to the development of targeted probiotic supplements to improve treatment outcomes.
A new study published in JAMA Surgery compares robotic liver resection with open liver resection for treating hepatocellular carcinoma. Robotic liver resection is found to be a safe treatment option for patients with compromised liver function, achieving comparable oncologic efficacy to traditional open surgery.
A recent study found metabolic perturbations in young nonhuman primates' liver and skeletal muscle after maternal obesity during pregnancy, even after a normal diet was introduced post-weaning. The study identified 58 altered metabolites in the liver and 46 in skeletal muscle, suggesting long-term health consequences.
Researchers found that a genetic mutation associated with liver disease confers different levels of risk depending on a patient's diabetic status. In diabetic patients, the mutation predisposes them to nonalcoholic fatty liver disease, but in nondiabetic patients, it protects against liver disease.
Researchers evaluated modified CEUS using perfluorobutane for diagnosing hepatocellular carcinoma in high-risk patients. The study found no significant difference in sensitivity, specificity, or accuracy between modified CEUS and CT/MRI LI-RADS v2018.
A study in Japan reveals that universal screening methods for biliary atresia, a rare and severe lung condition in infants, are cost-effective. The research found that stool color card screening and direct bilirubin testing gained significant clinical benefits and saved lives.
Scientists have created a way to track brain diseases like depression, Alzheimer's, and strokes using fluorescent mouse blood. The method allows for months-long study of blood flow in the brain, providing new insights into disease progression and development.
Research at Tel Aviv University found that high-intensity aerobic exercise increases glucose consumption in internal organs, reducing energy availability for tumors. The study reduced the risk of metastatic cancer in humans and animal models by up to 72%.
The University of Barcelona is the world-leading institution in research on liver cirrhosis, with a total of 177 published articles. Professor Pere Ginès has the top world citation index per article, highlighting the institution's scientific performance.
Researchers created an atlas of the malaria infection by Plasmodium parasites in the liver, revealing differences in infected cell localization and immune response. The study's findings hold promise for developing treatments targeting the asymptomatic liver stage of the disease.
Researchers have identified a parasitic protein unique to hypnozoites, which could serve as a potential biomarker of latent malaria vivax infections. The findings lay the groundwork for eliminating the disease by detecting its presence.
A recent study has found that simple tests can accurately predict the risk of secondary disease in hepatitis C patients after treatment. Non-invasive tests such as liver stiffness measurement and platelet count have been shown to be effective in identifying patients at high risk of developing portal hypertension.
A new study found that afternoon or evening physical activity is associated with reduced liver fat content and improved insulin sensitivity. Performing MVPA in the afternoon or evening was linked to reduced insulin resistance by 18% and 25% respectively.
Researchers found that first-degree relatives of patients with advanced fibrosis are at a 15% risk of developing nonalcoholic fatty liver disease. Early screening for advanced fibrosis among siblings and offspring of patients can help prevent the progression to cirrhosis or liver failure.
Researchers found that male mice were three times more likely to survive E. coli infection due to sex-biased lipid metabolism, which may hold risks for males in today's high-calorie environment. The study identified a signaling pathway regulating lipids and growth hormone as potential therapeutic targets for fatty liver disease.
Helmholtz Munich researchers identified a novel strategy to alter glucagon receptor signaling by changing its intracellular localization. This approach offers therapeutic potential for treating type 2 diabetes by uncoupling glucose and lipid metabolism-related effects.
A study found that leptin stimulates liver fat export and lowers liver fat content in healthy men, suggesting a new approach for treating fatty liver disease. The findings imply that the brain plays a role in liver fat metabolism via the autonomic nervous system, opening up potential new treatment options.
Researchers identified protein levels that were higher or lower than normal in tissues from individuals at different stages of type 2 diabetes. The study found a correlation between metabolic pathway disturbances and disease progression, suggesting new potential causal mechanisms for the disease.
Researchers found that liver cells cannot undergo necroptosis, a form of cell death previously thought to drive liver diseases. This revelation points to a new therapeutic intervention strategy and resolves crucial unanswered questions in the field.
Researchers found that hepatocyte adenosine kinase promotes excessive fat deposition and liver inflammation, suggesting a key role in the pathogenesis of nonalcoholic fatty liver disease. Dietary changes may help prevent or reduce NAFLD severity by inhibiting ADK activity.